Microvascular Complications Linked to Severity of Periodontitis

Share this content:
Microvascular Complications Linked to Severity of Periodontitis
Microvascular Complications Linked to Severity of Periodontitis

MONDAY, Feb. 6, 2017 (HealthDay News) -- Microvascular complications and poor glycemic control are associated with the severity of periodontitis, according to a study published online Jan. 27 in the Journal of Diabetes Investigation.

Hiroshi Nitta, D.D.S., Ph.D., from Tokyo Medical and Dental University, and colleagues conducted a multicenter study involving 620 patients with type 2 diabetes. The authors compared the prevalence and severity of periodontitis between patients with at least one microvascular complication versus those without microvascular complications, and among patients with different degrees of glycemic control.

The researchers found that the severity of periodontitis was significantly correlated with the number of microvascular complications, hemoglobin A1c (HbA1c) ≥8.0 percent, and older age (≥50 years), after adjustment for confounding variables (odds ratios, 1.3, 1.6, and 1.7, respectively). Periodontitis prevalence was not significantly associated with the number of microvascular complications, but there were correlations with male sex, high HbA1c (≥8.0 percent), older age (≥40 years), longer diabetes duration (≥15 years), and fewer teeth (≤25). The incidence of severe periodontitis was significantly higher among patients with versus those without microvascular complications in propensity score matching for age, sex, diabetes duration, and HbA1c (P < 0.05).

"The number of microvascular complications is a risk factor for more severe periodontitis in patients with type 2 diabetes, while poor glycemic control is a risk factor for increased prevalence and severity of periodontitis," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »